Approval · Notice of Compliance 27598 · 2022
EYLEA: Notice of Compliance 27598
Issued February 10, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27598
- Date
- February 10, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a dosing regimen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EYLEA | Not yet assigned | — |
Medicinal ingredients
- AFLIBERCEPT 2 MG per 0.05ML
- AFLIBERCEPT 20 MG per SYR